Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Composite outcomes in randomized trials: greater precision but with greater uncertainty?

Freemantle N, Calvert M, Wood J, Eastaugh J, Griffin C.

JAMA. 2003 May 21;289(19):2554-9.

PMID:
12759327
2.

Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials.

Ferreira-González I, Busse JW, Heels-Ansdell D, Montori VM, Akl EA, Bryant DM, Alonso-Coello P, Alonso J, Worster A, Upadhye S, Jaeschke R, Schünemann HJ, Permanyer-Miralda G, Pacheco-Huergo V, Domingo-Salvany A, Wu P, Mills EJ, Guyatt GH.

BMJ. 2007 Apr 14;334(7597):786. Epub 2007 Apr 2. Review.

3.

Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review.

Cordoba G, Schwartz L, Woloshin S, Bae H, Gøtzsche PC.

BMJ. 2010 Aug 18;341:c3920. doi: 10.1136/bmj.c3920. Review.

4.

Randomized, controlled clinical trials in sepsis: has methodological quality improved over time?

Graf J, Doig GS, Cook DJ, Vincent JL, Sibbald WJ.

Crit Care Med. 2002 Feb;30(2):461-72. Review.

PMID:
11889331
5.

Quality of reporting of randomized controlled trials of pharmacologic treatment of bipolar disorders: a systematic review.

Strech D, Soltmann B, Weikert B, Bauer M, Pfennig A.

J Clin Psychiatry. 2011 Sep;72(9):1214-21. doi: 10.4088/JCP.10r06166yel. Epub 2011 Jan 25. Review.

PMID:
21294992
6.

Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials.

Sun X, Briel M, Busse JW, Akl EA, You JJ, Mejza F, Bala M, Diaz-Granados N, Bassler D, Mertz D, Srinathan SK, Vandvik PO, Malaga G, Alshurafa M, Dahm P, Alonso-Coello P, Heels-Ansdell DM, Bhatnagar N, Johnston BC, Wang L, Walter SD, Altman DG, Guyatt GH.

Trials. 2009 Nov 9;10:101. doi: 10.1186/1745-6215-10-101. Review.

7.
8.

From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology.

Raghav KP, Mahajan S, Yao JC, Hobbs BP, Berry DA, Pentz RD, Tam A, Hong WK, Ellis LM, Abbruzzese J, Overman MJ.

J Clin Oncol. 2015 Nov 1;33(31):3583-90. doi: 10.1200/JCO.2015.62.4148. Epub 2015 Aug 24. Review.

9.
10.

The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias.

Tharmanathan P, Calvert M, Hampton J, Freemantle N.

BMC Med Res Methodol. 2008 Mar 20;8:12. doi: 10.1186/1471-2288-8-12. Review.

11.
12.

Prenatal interventions for congenital diaphragmatic hernia for improving outcomes.

Grivell RM, Andersen C, Dodd JM.

Cochrane Database Syst Rev. 2015 Nov 27;(11):CD008925. doi: 10.1002/14651858.CD008925.pub2. Review.

PMID:
26611822
13.

Randomized trial of epidural injections for spinal stenosis published in the New England Journal of Medicine: further confusion without clarification.

Manchikanti L, Candido KD, Kaye AD, Boswell MV, Benyamin RM, Falco FJ, Gharibo CG, Hirsch JA.

Pain Physician. 2014 Jul-Aug;17(4):E475-88. Review.

14.

Transfusion of fresher versus older red blood cells for all conditions.

Brunskill SJ, Wilkinson KL, Doree C, Trivella M, Stanworth S.

Cochrane Database Syst Rev. 2015 May 12;(5):CD010801. doi: 10.1002/14651858.CD010801.pub2. Review.

PMID:
25963030
15.

Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.

Chang LW, Harris J, Humphreys E.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008494. doi: 10.1002/14651858.CD008494. Review.

PMID:
20393969
16.

Survival end point reporting in randomized cancer clinical trials: a review of major journals.

Mathoulin-Pelissier S, Gourgou-Bourgade S, Bonnetain F, Kramar A.

J Clin Oncol. 2008 Aug 1;26(22):3721-6. doi: 10.1200/JCO.2007.14.1192. Review.

PMID:
18669458
17.

Are multiple primary outcomes analysed appropriately in randomised controlled trials? A review.

Vickerstaff V, Ambler G, King M, Nazareth I, Omar RZ.

Contemp Clin Trials. 2015 Nov;45(Pt A):8-12. doi: 10.1016/j.cct.2015.07.016. Epub 2015 Jul 26. Review.

PMID:
26215934
18.

Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients.

Johansen M, Wikkelsø A, Lunde J, Wetterslev J, Afshari A.

Cochrane Database Syst Rev. 2015 Jul 7;(7):CD010555. doi: 10.1002/14651858.CD010555.pub2. Review.

PMID:
26151108
19.

Randomized controlled trials and neurosurgery: the ideal fit or should alternative methodologies be considered?

Mansouri A, Cooper B, Shin SM, Kondziolka D.

J Neurosurg. 2016 Feb;124(2):558-68. doi: 10.3171/2014.12.JNS142465. Epub 2015 Aug 28. Review.

PMID:
26315006
20.

Reporting of time-to-event end points and tracking of failures in randomized trials of radiotherapy with or without any concomitant anticancer agent for locally advanced head and neck cancer.

Le Tourneau C, Michiels S, Gan HK, Siu LL.

J Clin Oncol. 2009 Dec 10;27(35):5965-71. doi: 10.1200/JCO.2009.22.3685. Epub 2009 Oct 5. Review.

PMID:
19805677

Supplemental Content

Support Center